JNCASR Scientists Innovate for Diabetic Patients


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ jncasr-scientists-innovate-diabetic-patients-insulin-silk-fibroin
JNCASR scientists develop injectable Silk Fibroin-based hydrogel for sustained Insulin delivery in diabetic patients

Scientists at Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an autonomous research institute under the Department of Science and Technology, have recently developed an injectable Silk fibroin-based hydrogel for sustained insulin delivery in diabetic patients. A patent application has also been filed for this invention.

Prof. T. Govindaraju and his research team from JNCASR have developed the silk fibroin (SF) formulation using biocompatible additives and prepared an injectable SF hydrogel (iSFH) that can ease insulin delivery in diabetic patients. The iSFH has demonstrated successful delivery of active insulin in rats, and the results have been published in the journal ACS Applied Bio Materials.

The JNCASR scientists have shown that subcutaneous injection of insulin with-iSFH in diabetic rats formed active depot under the skin from which insulin trickled out slowly and restored the physiological glucose homeostasis for a prolonged period of 4 days with no risks of low blood sugar through sudden burst of high concentration of insulin into the blood.

The viscous additives used by the team restricted the mobility of SF protein backbones and results in the rapid gelation. The microstructures provide mechanical strength (to support injectability), and porous morphology of iSFH allowed the encapsulation of human recombinant insulin in its active form in diabetic rats.

Diabetes affects more than 70 million people in India, the second-highest in the world. It results from inadequate production of insulin due to loss of beta cells or insulin resistance within the body, which imbalances the glucose homeostasis is leading to an abrupt increase of blood glucose level.

The conventional and last resort of treatment involves repeated subcutaneous insulin injections to maintain the physiological glucose homeostasis. The multiple subcutaneous insulin injections are associated with pain, local tissue necrosis, infection, nerve damage, and locally concentrated insulin amyloidosis responsible for inability to achieve physiological glucose homeostasis. This problem can be overcome with controlled and sustained insulin delivery. Thus, encapsulation and sustained delivery of insulin in its active form (without loss of activity) is the key to the development of such controlled and sustained in vivo delivery of Insulin.

The iSFH has proved to be an effective insulin delivery tool for diabetic patients with excellent mechanical strength, biocompatibility, encapsulation, storage, and demonstration of its sustained delivery of active insulin in the diabetic animal. The active encapsulation and delivery of insulin by iSFH may also have implications for the future development of formulations for oral insulin delivery. The JNCASR team hopes that pharmaceutical companies will come forward and further develop it for human use.

Tags : #JNCASRScientists #DiabeticPatients #Insulin #ProfTGovindraju

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026